Inspra

Eplerenone, the active ingredient in Inspra, is an aldosterone antagonist presented as an oral tablet for oral use. It treats essential hypertension, heart failure with reduced ejection fraction, and post‑myocardial infarction left ventricular dysfunction in adults.

GNH USA supplies Inspra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inspra (eplerenone) acts on the mineralocorticoid pathway to manage cardiovascular conditions.

Essential hypertension: lowers blood pressure by reducing sodium and water retention. Heart failure with reduced ejection fraction: improves cardiac function by decreasing fluid overload. Post‑myocardial infarction left ventricular dysfunction: helps prevent adverse remodeling and progression of heart failure.

Eplerenone may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Hyperkalemia: elevated serum potassium levels. - Dizziness or light‑headedness. - Headache. - Gastrointestinal discomfort or nausea. - Fatigue or weakness. - Increased serum creatinine.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Acute renal impairment. - Allergic reactions such as rash or pruritus. - Angioedema. - Hepatic dysfunction. - Endocrine disturbances, including gynecomastia (rare).

Before initiating eplerenone therapy, several safety considerations should be observed.

Monitor serum potassium: check levels regularly, especially in renal impairment. Assess renal function: adjust use if eGFR is reduced. Avoid use in patients with hyperkalemia: contraindicated. Caution with concomitant potassium‑sparing diuretics: risk of elevated potassium. Pregnancy and lactation: use only if benefits outweigh risks. Store at ambient temperature: keep below 25 °C, protect from moisture and light.

Eplerenone can interact with several drug classes, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Potassium supplements: may cause dangerous hyperkalemia. - ACE inhibitors or ARBs: increase risk of hyperkalemia. - Heparin: can potentiate hyperkalemia.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may affect electrolyte balance. - Digoxin: monitor for toxicity due to potassium changes.